Design Considerations for Pivotal Clinical Investigations for Medical Devices

Event Information
Product Format
Prerecorded Event
Conference Date
Wed, Mar 26, 2014
90 Minutes
Product Description

Get Insights on the Scope of FDA’s November, 2013 Guidance

While the FDA  has articulated policies related to design of studies intended to support specific device types , and a general policy of tailoring the evidentiary burden to the regulatory requirement, the Agency has not, in the past, attempted to describe the different clinical study designs that may be appropriate to support a device pre-market submission, or to define how a sponsor should decide which pivotal clinical study design should be used to support a submission for a particular device.

In November 2013 the Guidance “Design Considerations for Pivotal Clinical Investigations for Medical Devices” was issued, to provide guidance to Industry, Clinical Investigators and Institutional Review Boards, on the study design principles relevant to the development of medical device clinical studies. Even though this guidance is focused on providing recommendations to sponsors on how to design clinical investigations to support a PMA, sponsors who conduct clinical studies to support pre-market notification (510(k)) and de novo submissions may also rely on the principles in this guidance document.

A medical device pivotal study is a definitive study in which evidence is gathered to support the safety and effectiveness evaluation of the medical device for its intended use. Evidence from one or more pivotal clinical studies generally serves as the primary basis for the determination of reasonable assurance of safety and effectiveness of the medical device of a pre-market approval application (PMA) and FDA’s overall benefit-risk determination. In some cases, a PMA may include multiple studies designed to answer different scientific questions. In this audio session, Angela will present the FDA’s latest thinking on Design Considerations for Pivotal Clinical Investigations for Medical Devices.

Topics covered in the session:

  • Scope of FDA’s November, 2013 Guidance
  • Regulatory Framework for Level of Evidence and Study Design
  • Types of Medical Devices
  • The Importance of Exploratory Studies in Pivotal Study Design
  • Some Principles for the Choice of Clinical Study Design
  • Clinical Outcome Studies
  • Diagnostic Clinical Performance Studies
  • Sustaining the Quality of Clinical Studies
  • The Protocol

Ask a question in the Q&A session following the live event and get advice unique to your situation, directly from our expert speaker.

Who Should Attend:

  • Clinical Investigators
  • Biostatisticians
  • Regulatory Affairs
  • Quality Assurance

Order Below or Call 1-866-458-2965 Today

You can also order through:




About Our Speaker

Angela Bazigos - Pharma Conferences

Angela Bazigos is the CEO of Touchstone Technologies Inc. She has 40 years of experience in the Life Sciences & Healthcare Industries. Experience combines Quality Assurance, Regulatory Compliance, Business Administration, Information Technology, Project Management, Clinical Lab Science, Microbiology, Food Safety, Turnarounds and Business Development. Past employers / clients include Roche, Novartis, Genentech & PriceWaterhouseCoopers & Public Health Services companies. Positions include Chief Compliance Officer at Morf Media, Director of QA,...   More Info
More Events By The Speaker

Why AudioEducator?
  • Save money on travel.
  • Meet your specific training needs.
  • Keep learning after the event.
  • Save time training your whole staff.
Join Our Mailing List
Our Accreditation Partners
Facebook Twitter Linkedin Youtube RSS Feeds Google Plus